Is a complete DSE/ORIONPHARM research report available?

No complete published report is available for dse/ORIONPHARM (DSE/ORIONPHARM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/ORIONPHARM (DSE/ORIONPHARM)

Dhaka Stock Exchange: DSE/ORIONPHARM · BDT

BDT 28.7

+0.30 (+1.1%)· Recorded snapshot

Market cap	6.7B
Revenue (ttm)	3B
Net income (ttm)	-595.3M
EPS (ttm)	-BDT 2.54
Shares out	234M
Volume	519,808
Beta	-0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3B
Net income (ttm): -595.3M
EPS (ttm): -BDT 2.54
Market cap: 6.7B

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-11-12
Employees	2,954
Employees change	-206
Employees growth	-6.52%
Enterprise value	BDT 35B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1965
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BD0486OPL004
Last earnings date	2026-04-29
Last refreshed	2026-10-29
Last stock split date	2013-05-27
Last stock split type	Forward
Market cap	BDT 6.7B
Next earnings date	2026-11-12
Price	BDT 28.70
Price currency	BDT
SIC code	2834
Stock price date	2026-10-28
Symbol	dse/ORIONPHARM
Website	https://www.orionpharmabd.com

Metric

Value

Amount currency

BDT

Country

Bangladesh

Country code

Earnings date

2026-11-12

Employees

2,954

Employees change

-206

Employees growth

-6.52%

Enterprise value

BDT 35B

Exchange

Dhaka Stock Exchange

Financial currency

BDT

Financial report date

2026-03-31

First seen

2026-05-10

Fiscal year end

June

Founded

1965

Industry

Pharmaceutical Preparations

Is primary listing

Yes

ISIN number

BD0486OPL004

Last earnings date

2026-04-29

Last refreshed

2026-10-29

Last stock split date

2013-05-27

Last stock split type

Forward

Market cap

BDT 6.7B

Next earnings date

2026-11-12

Price

BDT 28.70

Price currency

BDT

SIC code

2834

Stock price date

2026-10-28

Symbol

dse/ORIONPHARM

Website

https://www.orionpharmabd.com

Metric	Value
Average P/E ratio (10Y)	19.91x
Average P/E ratio (5Y)	30.46x
Earnings yield	-8.86%
EV/EBITDA	80.31x
EV/FCF	87.39x
EV/Sales	11.63x
FCF / EV yield	1.14%
FCF yield	5.97%
Industry P/E	9.78x
P/B ratio	0.31x
P/FCF ratio	16.76x
P/OCF ratio	8.17x
P/S ratio	2.23x
Price / tangible book value	0.34x
Price/EBITDA ratio	16.33x

Metric

Value

Average P/E ratio (10Y)

19.91x

Average P/E ratio (5Y)

30.46x

Earnings yield

-8.86%

EV/EBITDA

80.31x

EV/FCF

87.39x

EV/Sales

11.63x

FCF / EV yield

1.14%

FCF yield

5.97%

Industry P/E

9.78x

P/B ratio

0.31x

P/FCF ratio

16.76x

P/OCF ratio

8.17x

P/S ratio

2.23x

Price / tangible book value

0.34x

Price/EBITDA ratio

16.33x

Metric	Value
EBIT margin	-4.48%
EBITDA margin	13.66%
FCF margin	13.31%
Gross margin	36.23%
Operating margin	-4.48%
Pretax margin	-18.62%
Profit margin	-19.77%
Profit per employee	BDT -201,525
Revenue per employee	BDT 1M
ROA	-0.15%
ROA (5Y)	1.15%
ROCE	-0.28%
ROE	-2.98%
ROE (5Y)	2.54%
ROIC	-0.28%
ROIC (5Y)	1.84%
Tax / revenue	3.06%

Metric

Value

EBIT margin

-4.48%

EBITDA margin

13.66%

FCF margin

13.31%

Gross margin

36.23%

Operating margin

-4.48%

Pretax margin

-18.62%

Profit margin

-19.77%

Profit per employee

BDT -201,525

Revenue per employee

BDT 1M

ROA

-0.15%

ROA (5Y)

1.15%

ROCE

-0.28%

ROE

-2.98%

ROE (5Y)

2.54%

ROIC

-0.28%

ROIC (5Y)

1.84%

Tax / revenue

3.06%

Metric	Value
Gross profit growth	-39.14%
Gross profit growth (Q)	50.55%
Gross profit growth 3Y	-23.84%
Gross profit growth 5Y	-15.01%
OCF growth	-60.79%
OCF growth (Q)	44.32%
OCF growth (QoQ)	-25.82%
OCF growth 10Y	-10.74%
OCF growth 3Y	-25.15%
OCF growth 5Y	-22.83%
Revenue growth	-51.37%
Revenue growth (Q)	75.93%
Revenue growth 10Y	-11.67%
Revenue growth 3Y	-43.61%
Revenue growth 5Y	-21.64%

Metric

Value

Gross profit growth

-39.14%

Gross profit growth (Q)

50.55%

Gross profit growth 3Y

-23.84%

Gross profit growth 5Y

-15.01%

OCF growth

-60.79%

OCF growth (Q)

44.32%

OCF growth (QoQ)

-25.82%

OCF growth 10Y

-10.74%

OCF growth 3Y

-25.15%

OCF growth 5Y

-22.83%

Revenue growth

-51.37%

Revenue growth (Q)

75.93%

Revenue growth 10Y

-11.67%

Revenue growth 3Y

-43.61%

Revenue growth 5Y

-21.64%

Metric	Value
Capital expenditures	BDT -421M
Depreciation and amortization	BDT 546.2M
EBIT	BDT -134.9M
EBITDA	BDT 411.3M
EPS	BDT -2.54
FCF per share	BDT 1.71
Financing cash flow	BDT -477.3M
Free cash flow	BDT 400.8M
Gross profit	BDT 1.1B
Income taxes	BDT 92.1M
Investing cash flow	BDT -336.1M
Net borrowing	BDT -341M
Net cash flow	BDT 8.3M
Net income	BDT -595.3M
Operating income	BDT -134.9M
Revenue	BDT 3B

Metric

Value

Capital expenditures

BDT -421M

Depreciation and amortization

BDT 546.2M

EBIT

BDT -134.9M

EBITDA

BDT 411.3M

EPS

BDT -2.54

FCF per share

BDT 1.71

Financing cash flow

BDT -477.3M

Free cash flow

BDT 400.8M

Gross profit

BDT 1.1B

Income taxes

BDT 92.1M

Investing cash flow

BDT -336.1M

Net borrowing

BDT -341M

Net cash flow

BDT 8.3M

Net income

BDT -595.3M

Operating income

BDT -134.9M

Revenue

BDT 3B

Metric	Value
Altman Z-Score	0.52
Book value per share	BDT 85.46
Debt / EBITDA	63.11
Debt / equity	1.26
Debt / FCF	67.46
Interest coverage	-0.31
Long-term assets	BDT 39.6B
Long-term liabilities	BDT 27.2B
Net cash (debt)	BDT -26.9B
Net cash / market cap	-400.22%
Net debt / EBITDA	65.35
Net debt / equity	1.25
Net debt / FCF	67.06
Piotroski F-Score	4
Property, plant and equipment	BDT 32.2B
Shareholders' equity	BDT 21.4B
Tangible book value	BDT 20B
Tangible book value per share	BDT 85.46
Total assets	BDT 57.1B
Total cash	BDT 148.3M
Total debt	BDT 27B
Total liabilities	BDT 35.7B
WACC	1.37%

Metric

Value

Altman Z-Score

0.52

Book value per share

BDT 85.46

Debt / EBITDA

63.11

Debt / equity

1.26

Debt / FCF

67.46

Interest coverage

-0.31

Long-term assets

BDT 39.6B

Long-term liabilities

BDT 27.2B

Net cash (debt)

BDT -26.9B

Net cash / market cap

-400.22%

Net debt / EBITDA

65.35

Net debt / equity

1.25

Net debt / FCF

67.06

Piotroski F-Score

Property, plant and equipment

BDT 32.2B

Shareholders' equity

BDT 21.4B

Tangible book value

BDT 20B

Tangible book value per share

BDT 85.46

Total assets

BDT 57.1B

Total cash

BDT 148.3M

Total debt

BDT 27B

Total liabilities

BDT 35.7B

WACC

1.37%

Metric	Value
Asset turnover	0.05
Current assets	BDT 17.5B
Current liabilities	BDT 8.5B
Current ratio	2.06
Inventory turnover	1.41
Net working capital	BDT 9.3B
Quick ratio	1.82
Working capital	BDT 9B
Working capital turnover	0.34

Metric

Value

Asset turnover

0.05

Current assets

BDT 17.5B

Current liabilities

BDT 8.5B

Current ratio

2.06

Inventory turnover

1.41

Net working capital

BDT 9.3B

Quick ratio

1.82

Working capital

BDT 9B

Working capital turnover

0.34

Metric	Value
Dividend growth (10Y)	-3.97%
Dividend growth (3Y)	-5.9%
Dividend growth (5Y)	-7.79%
Dividend per share	BDT 0.00
Last dividend	BDT 1.00

Metric

Value

Dividend growth (10Y)

-3.97%

Dividend growth (3Y)

-5.9%

Dividend growth (5Y)

-7.79%

Dividend per share

BDT 0.00

Last dividend

BDT 1.00

Metric	Value
10Y price change	-20.5%
10Y return CAGR	0.12%
10Y total return	1.21%
150-day SMA	BDT 27.59
1D price change	1.06%
1M price change	-0.69%
1M total return	-0.69%
1W price change	1.77%
1W total return	1.77%
1Y price change	-7.42%
1Y return CAGR	-7.42%
1Y total return	-7.42%
20-day SMA	BDT 27.80
200-day SMA	BDT 27.83
3M price change	-0.35%
3M total return	-0.35%
3Y price change	-63.94%
3Y return CAGR	-27.91%
3Y total return	-62.54%
50-day SMA	BDT 26.87
50-day SMA vs 200-day SMA	50under200
52-week high	BDT 33.20
52-week high date	2026-09-27
52-week low	BDT 22.90
52-week low date	2025-11-16
5Y price change	-73.93%
5Y return CAGR	-22.63%
5Y total return	-72.28%
6M price change	6.69%
6M total return	6.69%
All-time high	BDT 156.50
All-time high date	2022-09-21
All-time low	BDT 22.90
All-time low date	2025-11-16
Average true range (ATR)	BDT 1.54
Average volume	653.3K
Beta (1Y)	-0.06
Beta (2Y)	-0.23
Beta (5Y)	-0.45
Change from 52-week high	-13.55%
Change from 52-week low	25.33%
Change from all-time high	-81.66%
Change from all-time low	25.33%
Change from open	0.7%
Day's gap	0.35%
Dollar volume	BDT 14.9M
High price	BDT 29.00
Low price	BDT 28.40
Monthly RSI	39.6
Open price	BDT 28.50
Position in 52-week range	50%
Previous close	BDT 28.40
Price vs 150-day SMA	4.01%
Price vs 20-day SMA	3.26%
Price vs 200-day SMA	3.12%
Price vs 50-day SMA	6.8%
Relative volume	0.8
RSI	56.42
Sharpe ratio	-0.51
Sharpe ratio (3Y)	-0.76
Sharpe ratio (5Y)	-0.18
Sortino ratio	-0.65
Sortino ratio (3Y)	-1.01
Sortino ratio (5Y)	-0.14
Volume	519.8K
Weekly RSI	0
YTD price change	4.75%
YTD total return	4.75%

Metric

Value

10Y price change

-20.5%

10Y return CAGR

0.12%

10Y total return

1.21%

150-day SMA

BDT 27.59

1D price change

1.06%

1M price change

-0.69%

1M total return

-0.69%

1W price change

1.77%

1W total return

1.77%

1Y price change

-7.42%

1Y return CAGR

-7.42%

1Y total return

-7.42%

20-day SMA

BDT 27.80

200-day SMA

BDT 27.83

3M price change

-0.35%

3M total return

-0.35%

3Y price change

-63.94%

3Y return CAGR

-27.91%

3Y total return

-62.54%

50-day SMA

BDT 26.87

50-day SMA vs 200-day SMA

50under200

52-week high

BDT 33.20

52-week high date

2026-09-27

52-week low

BDT 22.90

52-week low date

2025-11-16

5Y price change

-73.93%

5Y return CAGR

-22.63%

5Y total return

-72.28%

6M price change

6.69%

6M total return

6.69%

All-time high

BDT 156.50

All-time high date

2022-09-21

All-time low

BDT 22.90

All-time low date

2025-11-16

Average true range (ATR)

BDT 1.54

Average volume

653.3K

Beta (1Y)

-0.06

Beta (2Y)

-0.23

Beta (5Y)

-0.45

Change from 52-week high

-13.55%

Change from 52-week low

25.33%

Change from all-time high

-81.66%

Change from all-time low

25.33%

Change from open

0.7%

Day's gap

0.35%

Dollar volume

BDT 14.9M

High price

BDT 29.00

Low price

BDT 28.40

Monthly RSI

39.6

Open price

BDT 28.50

Position in 52-week range

50%

Previous close

BDT 28.40

Price vs 150-day SMA

4.01%

Price vs 20-day SMA

3.26%

Price vs 200-day SMA

3.12%

Price vs 50-day SMA

6.8%

Relative volume

0.8

RSI

56.42

Sharpe ratio

-0.51

Sharpe ratio (3Y)

-0.76

Sharpe ratio (5Y)

-0.18

Sortino ratio

-0.65

Sortino ratio (3Y)

-1.01

Sortino ratio (5Y)

-0.14

Volume

519.8K

Weekly RSI

YTD price change

4.75%

YTD total return

4.75%

Metric	Value
Shares change (QoQ)	0%
Shares outstanding	234M

Metric

Value

Shares change (QoQ)

Shares outstanding

234M

DSE/ORIONPHARM (DSE/ORIONPHARM)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/ORIONPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/ORIONPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/ORIONPHARM

Frequently asked questions